<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200503047293N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-20</date_registration>
      <primary_sponsor>Research Institute of Ophthalmology</primary_sponsor>
      <public_title>Extra ocular muscle fenestration for surgical management of strabismus</public_title>
      <acronym></acronym>
      <scientific_title>Extra ocular muscle fenestration as a weakening maneuver for surgical management of strabismus : A randomized  pilot clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48091</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: We will use the sequentially numbered, opaque sealed envelopes method. We will use envelopes that are impermeable to intense light, and the allocation sequence will be concealed from the physicians enrolling and assessing participants. To prevent subversion of the allocation sequence, the name and hospital admission number of the participant will be written on the envelope. Carbon paper will transfer the information onto the allocation card inside the envelope. Corresponding envelopes will be opened only after the enrolled participants completes all baseline assessments and it is time to allocate the intervention, Blinding description: Since it is an operative procedure, only participants will be blinded to the type of intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Strabismus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1 (muscle fenestration): The rectus muscle will be exposed through a fornical conjunctival incision then the muscle will be stretched between 2 muscle hooks, and 2 peripheral muscle strips each 1 mm in width will be created using a fine muscle hook or by stripping the muscle fibers with a silk suture starting proximal at the desired site till the muscle insertion. Then, the 2 muscle strips will be separated on each side and the muscle belly in between will be excised leaving a bare sclera (a fenestration or a window defect). The conjunctiva will be re-positioned, and the surgery will be concluded. Intervention 2: Intervention group 2 (classic muscle recession): The muscle will be exposed by fornical incision. Dissection of the conjunctiva and tenon capsule will be done. Hooking of the muscle by Jameson hook and dissection of the intermuscular septum will be done. A Chavasse muscle hook will be exchanged with Jameson muscle hook, and the muscle will be secured with a coated double-armed Vicryl 6-0 suture with an s-29 needle. The desired amount of recession will be measured from the original insertion by a caliper. Scleral sutures will be taken at the superior and inferior edges parallel to the original insertion. The muscle will be pulled up to the level of the desired new insertion, making sure the sutures are taut and the muscle belly spreads nicely against the sclera. A knot will be tied with a double forehand throw, a single backhand throw, and a final single forehand throw. The sutures will then be cut 2 mm from knot. The conjunctiva is then closed with 2 interrupted Vicryl 8-0 sutures.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Extra ocular muscle fenestration IPD set (all collected deidentified IPD)

When:
beginning 6 months and ending 36 months following article publication

To whom:
Researchers from academic institutions whose proposal for the use of data has been approved by an independent review committee identified for this purpose

Conditions:
for IPD meta-analysis

Where to obtain:
from the PI

How to obtain:
A proposal for the use of data to be submitted to the PI, then evaluated by an independent review committee identified for this purpose

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Omar Hashem</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>2 El Ahram Street</address>
        <city>Giza</city>
        <country1>Egypt</country1>
        <zip>12557</zip>
        <telephone>+20 2 35718304</telephone>
        <email>hashemomar@yahoo.com</email>
        <affiliation>Research Institute of Ophthalmology</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sameh Galal</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>2 El Ahram Street</address>
        <city>Giza</city>
        <country1>Egypt</country1>
        <zip>12557</zip>
        <telephone>+20 2 35735688</telephone>
        <email>sameh.galal.1900@gmail.com</email>
        <affiliation>Research Institute of Ophthalmology</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Egypt</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients diagnosed with strabismus that requires surgical intervention after complete routine ophthalmological evaluation and evaluation of the angle of strabismus</inclusion_criteria>
      <agemin>1 year</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Previous strabismus surgery upon the target muscle
Previous orbital surgery, orbital masses, or orbital inflammatory diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H50.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified strabismus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1 (muscle fenestration): The rectus muscle will be exposed through a fornical conjunctival incision then the muscle will be stretched between 2 muscle hooks, and 2 peripheral muscle strips each 1 mm in width will be created using a fine muscle hook or by stripping the muscle fibers with a silk suture starting proximal at the desired site till the muscle insertion. Then, the 2 muscle strips will be separated on each side and the muscle belly in between will be excised leaving a bare sclera (a fenestration or a window defect). The conjunctiva will be re-positioned, and the surgery will be concluded.</i_keyword>
      <i_keyword>Intervention group 2 (classic muscle recession): The muscle will be exposed by fornical incision. Dissection of the conjunctiva and tenon capsule will be done. Hooking of the muscle by Jameson hook and dissection of the intermuscular septum will be done. A Chavasse muscle hook will be exchanged with Jameson muscle hook, and the muscle will be secured with a coated double-armed Vicryl 6-0 suture with an s-29 needle. The desired amount of recession will be measured from the original insertion by a caliper. Scleral sutures will be taken at the superior and inferior edges parallel to the original insertion. The muscle will be pulled up to the level of the desired new insertion, making sure the sutures are taut and the muscle belly spreads nicely against the sclera. A knot will be tied with a double forehand throw, a single backhand throw, and a final single forehand throw. The sutures will then be cut 2 mm from knot. The conjunctiva is then closed with 2 interrupted Vicryl 8-0 sutures.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Ocular balance (post operative ocular alignment ). Timepoint: Second day, one week, and one month post-operative. Method of measurement: By corneal light reflex, Krimisky test, and prism cover test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Ocular motility (freedom vs limitations). Timepoint: Second day, one week, and one month post-operative. Method of measurement: Assessment of versions and ductions.</sec_outcome>
      <sec_outcome>Post-operative pain. Timepoint: Second day, one week, and one month post-operative. Method of measurement: Asking the patient about post operative pain and giving a pain score from 1 to 5.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Self-funded</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-02-23</approval_date>
        <contact_name>Research Ethical Committee of the Research Institute of Ophthalmology</contact_name>
        <contact_address>2 El Ahram Street Giza Cairo Egypt</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
